−0.0366USD
−3.90 MUSD
51.34 M
About Tryp Therapeutics Inc.
Sector
CEO
Jason Carroll
Headquarters
Kelowna
Website
Founded
2019
FIGI
BBG00Z61SWC9
Tryp Therapeutics, Inc. is a pharmaceutical company, which engages in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company was founded on September 24, 2019 and is headquartered in Kelowna, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TRYPF is 0.0470 USD — it has increased by 9.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Tryp Therapeutics Inc. stocks are traded under the ticker TRYPF.
TRYPF stock is 17.45% volatile and has beta coefficient of −3.73. Check out the list of the most volatile stocks — is Tryp Therapeutics Inc. there?
Yes, you can track Tryp Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
TRYPF stock has risen by 30.56% compared to the previous week, the month change is a 186.59% rise, over the last year Tryp Therapeutics Inc. has showed a 32.57% decrease.
TRYPF net income for the last quarter is −855.37 K USD, while the quarter before that showed −1.25 M USD of net income which accounts for 31.59% change. Track more Tryp Therapeutics Inc. financial stats to get the full picture.
Today Tryp Therapeutics Inc. has the market capitalization of 4.22 M, it has increased by 11.05% over the last week.
No, TRYPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TRYPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tryp Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tryp Therapeutics Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tryp Therapeutics Inc. stock shows the neutral signal. See more of Tryp Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.